OncoMed Pharmaceuticals Secures $81,600,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=625e1440-d7ed-42ef-a36d-eefb88b4b14e - Date
7/18/2013 - Company Name
OncoMed Pharmaceuticals - Mailing Address
800 Chesapeake Drive Redwood City, CA 94063 - Company Description
OncoMed Pharmaceuticals (NASDAQ: OMED) is discovering and developing monoclonal antibodies and small molecules capable of destroying cancer stem cells, a recently discovered type of cell believed to seed the growth of cancers and underlie cancer’s ability to spread and take root in tissues. - Website
http://www.oncomed.com - Transaction Type
IPO - Transaction Amount
$81,600,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
